Cleared Traditional

K260563 - CN-Suite™

K260563 is an FDA 510(k) clearance for CN-Suite, manufactured by FIND Surgical Sciences Inc. D/B/A FIND Neuro. The device is a Class 2 Neurology device with product code OLX cleared through the Traditional 510(k) pathway after a 178-day FDA review.

K260563 · FIND Surgical Sciences Inc. D/B/A FIND Neuro · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2026
Decision
178d
Days
Class 2
Risk

K260563 is an FDA 510(k) clearance for the CN-Suite™. Classified as Source Localization Software For Electroencephalograph Or Magnetoencephalograph (product code OLX), Class II - Special Controls.

Submitted by FIND Surgical Sciences Inc. D/B/A FIND Neuro (Cambridge, US). The FDA issued a Cleared decision on August 16, 2026 after a review of 178 days - an extended review cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all FIND Surgical Sciences Inc. D/B/A FIND Neuro devices

FDA 510(k) Submission Details - K260563

510(k) Number K260563 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2026
Decision Date August 16, 2026
Days to Decision 178 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
30d slower than avg
Panel avg: 148d · This submission: 178d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

OLX Device Classification - Class 2, Special Controls

Product Code OLX Source Localization Software For Electroencephalograph Or Magnetoencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Correlation Of Electrical Activity Of The Brain Using Various Neuroimaging Modalities For Source-localization
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Consultant

Healthcare Innovation Catalysts, Inc.
Brittany Valdez Nava

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - OLX Source Localization Software For Electroencephalograph Or Magnetoencephalograph

All 13
Devices cleared under the same product code (OLX) and FDA review panel - the closest regulatory comparables to K260563.
PreOp v3
K252565 · Clouds of Care · Feb 2026
NeuroMatch
K250239 · LVIS Corporation · May 2025
Sourcerer
K241513 · Brain Electrophysiology Laboratory Company, LLC · Sep 2024
TRIUX™ neo (NM27000N )
K233985 · Megin OY · May 2024
RICOH MEG
K210199 · Ricoh Company, Ltd. · Jul 2021
EZTrack
K201910 · Neurologic, LLC · Dec 2020